Zimmer Biomet
810 hedge funds and large institutions have $22.7B invested in Zimmer Biomet in 2016 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 261 increasing their positions, 294 reducing their positions, and 28 closing their positions.
186% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 28
10% more funds holding in top 10
Funds holding in top 10: 20 → 22 (+2)
6% more funds holding
Funds holding: 766 → 810 (+44)
5% more capital invested
Capital invested by funds: $21.6B → $22.7B (+$1.14B)
6% more call options, than puts
Call options by funds: $52.9M | Put options by funds: $50M
2.41% less ownership
Funds ownership: 92.53% → 90.11% (-2.4%)
11% less repeat investments, than reductions
Existing positions increased: 261 | Existing positions reduced: 294
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$175M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$103M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$92.4M |
| 4 |
Millennium Management
New York
|
+$91.6M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$78.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$453M |
| 2 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$442M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$161M |
| 4 |
Goldman Sachs
New York
|
-$135M |
| 5 |
SI
Sentry Investments
Toronto,
Ontario, Canada
|
-$66.6M |
ZBH Hedge Fund Activity: Q3 2016 in Review
810 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q3 2016, worth a combined $22.7B — up 5.3% from $21.6B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new ZBH positions and 28 closed out — a net gain of 52 holders — while 261 added to existing stakes and 294 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $175M. The largest seller was Kohlberg Kravis Roberts & Co, exiting entirely with an estimated $453M sold.
- 810 institutional investors held Zimmer Biomet (ZBH) as of Q3 2016, up from 766 in Q2 2016.
- Funds reported $22.7B of Zimmer Biomet stock for Q3 2016, up 5.3% quarter-over-quarter.
- 80 funds opened new Zimmer Biomet positions in Q3 2016 and 28 closed out, a net change of +52 holders.
- The largest Zimmer Biomet buyer in Q3 2016 was Fidelity Investments, an estimated $175M added.
- The largest Zimmer Biomet seller in Q3 2016 was Kohlberg Kravis Roberts & Co, an estimated $453M sold.
Based on aggregated 13F filings for Q3 2016.